Clotri-Denk100 Vaginal

Negara: Armenia

Bahasa: Inggris

Sumber: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Bahan aktif:

clotrimazole

Tersedia dari:

Artesan Pharma GmbH & Co. KG

INN (Nama Internasional):

clotrimazole

Dosis:

100mg

Bentuk farmasi:

tablets vaginal

Jenis Resep:

Prescription

Selebaran informasi

Clotri-Denk 100 Vaginal
Antifungal agent
Do not swallow – for insertion into the
vagina
Active ingredient: clotrimazole
1 vaginal tablet contains 100 mg clotrima-
zole.
PACKAGE LEAFLET:
INFORMATION FOR THE USER
READ THIS LEAFLET CAREFULLY BEFORE YOU
START USING THIS MEDICINE.
– Keep this leaflet. You may need to
read it again.
– Ask your doctor or pharmacist if you
have any further questions.
– You must contact a doctor if your
symptoms worsen or do not improve.
– If any of the side effects gets serious,
or if you notice any side effects not
listed in this leaflet, please tell your
doctor or pharmacist.
IN THIS LEAFLET
1.WHAT CLOTRI-DENK 100 VAGINAL IS AND
WHAT IT IS USED FOR
2.BEFORE YOU USE CLOTRI-DENK 100 VAGINAL
3.HOW TO USE CLOTRI-DENK 100 VAGINAL
4.POSSIBLE SIDE EFFECTS
5.HOW TO STORE CLOTRI-DENK 100 VAGINAL
6.FURTHER INFORMATION
1.
WHAT CLOTRI-DENK 100 VAGINAL IS
AND WHAT IT IS USED FOR
Clotri-Denk 100 Vaginal is a drug used in
the treatment of vaginal fungal infections.
Clotrimazole, the active ingredient of
Clotri-Denk 100 Vaginal, acts by inhibiting
the growth and proliferation of fungal cells,
such as yeasts (usually candida species) as
well as a number of other fungal elements
and some bacteria.
CLOTRI-DENK 100 VAGINAL IS USED FOR
vaginal inflammation and discharge caused
by a fungus (usually candida).
2.
BEFORE YOU USE
CLOTRI-DENK 100 VAGINAL
DO NOT USE CLOTRI-DENK 100 VAGINAL
if you are allergic (hypersensitive) to clotri-
mazole or any of the other ingredients.
TAKE SPECIAL CARE WITH
CLOTRI-DENK 100 VAGINAL
The concomitant application of latex prod-
ucts (e.g. condom or diaphragma) can cause
a reduced function of these products and
therefore a reduction in security due to the
excipients of Clotri-Denk 100 Vaginal.
TAKING OTHER MEDICINES
Please tell your doctor or pharmacist if you
are taking or have recently taken any other
medicines, including medicines obtained
without a prescription.
Clotri-Denk 100 Vaginal reduces the effi-
cacy of other pharmaceuticals which are
also taken for treatm

Karakteristik produk

Application for registration of
_Clotri-Denk 100 Vaginal _
1/ 6
S
UMMARY OF PRODUCT CHARACTERISTICS
1.
NAME AND PRESENTATION FORM OF THE MEDICINAL PRODUCT
_Clotri-Denk 100 Vaginal _
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Active ingredient: Clotrimazole.
One vaginal tablet contains 100 mg clotrimazole.
Excipients: Please refer to item 6.1 for a complete list of other
excipients.
3.
PHARMACEUTICAL FORM
Vaginal tablet.
For insertion into the vagina
White, bean-shaped vaginal tablet.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Vaginal discharge caused by yeasts, vaginal infections where fungi are
present or suspected
(usually candida species).
4.2
POSOLOGY, METHOD AND DURATION OF ADMINISTRATION
One vaginal tablet is inserted daily as deep as possible for six
consecutive days, preferably at
night.
Clotri-Denk 100 Vaginal is best given with the patient lying on her
back with her legs slightly
bent up.
During pregnancy vaginal treatment should be performed without an
applicator.
It is not advisable to administer treatment during a period
(menstruation). Treatment should
be finished before the onset of menstruation. The medication should
only be administered
during menstruation if symptoms are severe.
To avoid possible re-infection the partner should be examined at the
same time.
Generally, a course of treatment lasting 6 days is adequate. The
treatment can be repeated
where necessary.
The treatment must be applied regularly and for an adequate period of
time in order for it to
be effective.
4.3
CONTRA-INDICATIONS
_Clotri-Denk 100 Vaginal_ should not be used in case of known
hypersensitivity to clotrimazole or
one of the other ingredients.
Application for registration of
_Clotri-Denk 100 Vaginal _
2/ 6
Application under medical supervision if: first occurence of the
disease, occurence more than 4
times during the last 12 months, the patient is younger than 18 years.
4.4
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
The concomitant application of latex products (e.g. condom or
diaphragma) can cause a reduced
funct